Regenicin Information

Regenicin, Inc. is a biotechnology company dedicated to advancing regenerative cell therapies to repair and restore damaged tissues and organs. Founded in 2010, Regenicin has built a world-class management team with a strong track record in developing and commercializing innovative medical devices and biotechnology products. The company is focused on bringing NovaDerm®—a breakthrough autologous cultured skin substitute—to market. NovaDerm® is a tissue-engineered skin graft that utilizes a patient’s own skin cells to create living, regenerative skin for treating severe burns and chronic wounds. Regenicin is headquartered in Las Vegas, NV.

Website	http://www.regenicin.com
Ticker	RGIN
Revenue	$4000
Employees	9 (2 on RocketReach)
Founded	2010
Phone	+1 973-557-8914
Industry	Manufacturing, Business Services General, Biotechnology, Machinery (B2B), Business Services, Science and Engineering, Pharmaceutical, Health Care
Web Rank	17 Million
Keywords	Medical Research, Regenerative Medicine, Biomedical Research, Cell Therapy, Tissue Regeneration, Innovative Treatments, Stem Cell Treatment, Wound Healing, Biotechnology, Pharmaceutical Research, Clinical Trials, Drug Development, Medical Innovation, Healthcare Technology, Biological Therapies, Regenerative Solutions, Advanced Therapies, Cellular Therapies, Tissue Engineering, Therapeutic Innovation
Competitors	Medtronic, Boston Scientific, Zimmer Biomet, Smith+Nephew, Integra LifeSciences, Organogenesis, Acelity, Sientra, Inc., MediWound Ltd., Tissue Regenix Group +32 more (view full list)
SIC	SIC Code 283 Companies, SIC Code 28 Companies, SIC Code 87 Companies, SIC Code 873 Companies
NAICS	NAICS Code 541 Companies, NAICS Code 325414 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 54 Companies, NAICS Code 32 Companies